GlaxoSmithKline: AIDS-Related Complex trials

The registry lists 21 AIDS-Related Complex studies with GlaxoSmithKline as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 2Phase 3 4No phase 13(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Safety and Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Taken AZTCompletedNCT00002436Phase 3
• A Study of 1592U89 Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV DrugsCompletedNCT00002364Phase 2
• A Comparison of Atovaquone and Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia in HIV-Infected Patients Who Cannot Take TMP/SMXCompletedNCT00002340Phase 3
• The Safety and Effectiveness of 935U83 in HIV-Infected PatientsCompletedNCT00002338Phase 1
• The Safety and Effectiveness of 524W91CompletedNCT00002335Phase 1
• A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the PastCompletedNCT00002320Phase 3
• A Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients With Weakened Immune SystemsCompletedNCT00002315Phase 3
• The Safety and Effectiveness of Zidovudine Plus Acyclovir in Patients With Early HIV InfectionCompletedNCT00002290Not applicable
• The Safety and Effectiveness of Retrovir in HIV-Infected Patients Who Have Problems Related to the Nervous SystemCompletedNCT00002288Not applicable
• A Study of Azidothymidine (AZT) in the Treatment of HIV Infection in Patients Receiving a Bone Marrow TransplantCompletedNCT00002284Not applicable
• 3TC (Lamivudine; GR109714X) Open-Label ProgramCompletedNCT00002108Not applicable
• A Randomized Trial to Evaluate the Safety and Efficacy of Combination Therapy With Retrovir ( AZT ) and HIVID ( ddC ) Versus Retrovir, HIVID, and Wellferon ( Interferon Alfa-n1 ) for the Treatment of HIV InfectionCompletedNCT00002086Phase 2
• A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected PatientsCompletedNCT00002084Not applicable
• Treatment of AIDS and AIDS Related Complex. Part-1- Treatment of Patients With ARC (AZT Vs. Placebo)CompletedNCT00002063Not applicable
• Retrovir Capsules in the Treatment of HIV-Infected Patients in Renal FailureCompletedNCT00002047Not applicable
• A Dose-Frequency Trial of Oral Retrovir in Patients With AIDS or Severe ARCCompletedNCT00002046Not applicable
• A Pilot Study To Evaluate the Effect of Retrovir (Zidovudine: AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Associated Dementia and Neuromuscular DiseasesCompletedNCT00002044Not applicable
• Treatment and Suppression of Hairy Leukoplakia in ARC Patients With Oral Acyclovir (ACV)CompletedNCT00002026Not applicable
• An Oral Dose-Ranging Finding Study in Patients With HIV Disease, CDC Classification Groups IIB, III, and IV-C2CompletedNCT00002023Not applicable
• Trial of an Alternative Dosing Regimen of Oral Retrovir in Patients With AIDS or Advanced ARCCompletedNCT00002020Not applicable
• A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected PatientsCompletedNCT00002000Not applicable